Dianthus Therapeutics | MGTA - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Celltrion KRW 39.29B 7.7B 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD -566M 792M 2026-03
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Organon & Co USD 847M 64M 2026-06
Pharma Mar EUR 44.87M 5.63M 2026-06
Qiagen NV USD 340.39M 30.78M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 57.47M 10.16M 2025-06
Viatris USD 1.57B 193.9M 2026-06
Xeris Pharmaceuticals USD 72.55M 404K 2026-03
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03